Unfractionated Heparin
Stroke of Basilar Artery
Sunnybrook Health Sciences CentreN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Stroke of Basilar Artery cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tenecteplase Xuanwu Hospital, Beijing | Phase 4 | BBB |
Recombinant Human Plasminogen Activator The First Affiliated Hospital of University of Science and Technology of China | Phase 3 | BB |
Arestin Xijing Hospital | Phase 4 | BB |
Cerebrolysin University Hospital Sestre Milosrdnice | Early Phase 1 | C |
Acetylsalicylic Acid Sunnybrook Health Sciences Centre | N/A | D |
Same molecule, other indications
Unfractionated Heparin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →